CD BioSciences Launches Cell Death Solutions for Life Science Researchers

Top Quote CD BioSciences recently announced the launch of a comprehensive panel of research solutions covering all aspects of cell death study. End Quote
  • (1888PressRelease) October 22, 2022 - CD BioSciences, a US-based CRO serving the global life science research community, recently announced the launch of a comprehensive panel of research solutions covering all aspects of cell death study, such as Mechanism Study, Phenotype Analysis, Cell Death Characterization, and Chemical Screening.

    Cell death is a fundamental biological process, and it has been extensively studied over the past few decades. Characterized by different morphologies, apoptosis, autophagic cell death, and necrosis are the three main types of cell death. In multicellular organisms, cell death is the process by which cells cease to function, so maintaining tissue homeostasis and eliminating potentially harmful cells is critical.

    While cell death can be caused by overwhelming damage, most are the result of specific signaling events. In particular, active cell death (apoptosis, necroptosis, pyroptosis, ferroptosis, alkalosis, and hypoxia) is tightly regulated by signaling pathways. Since cell death is closely related to disease, in-depth characterization of cell death events may uncover new therapeutic targets. As a trusted CRO, CD BioSciences offers comprehensive solutions covering all aspects of life science research, including cell death.

    "Life science researchers face many hurdles, but now a series of solutions for studying cell death signaling pathways are ready for your scientific studies," said Kristy J. Morris, the marketing director at CD BioSciences. "As scientists are looking to accelerate the life sciences studies, there is an urgent need for more support at early stages of development. With advanced technologies, dedicated scientists, as well as the resources for programs, we believe we can play a significant role in advancing science. Furthermore, we'll continue to work with our customers, strengthen our workforce, and offer more research solutions for different research areas."

    There are various options for researchers to choose from, including Regulator Identification that identifies gene regulators participating in a certain cell death signaling pathway; Mechanism Study that investigates the regulation mechanism of a certain regulator; Phenotype Analysis that analyzes the cellular phenotypes regulated by gene/protein of interest; Cell Death Characterization that identifies and characterizes the types of cell death under certain conditions; and Chemical Screening that screens inhibitors or activators of certain types of cell death.

    Additionally, CD BioSciences also provides Metabolic Signaling Pathways, such as the mTOR Pathway, Insulin Signaling Pathway and AMPK pathway, to support researchers focusing on the study of metabolism and metabolic disease and provide a better and deeper understanding of metabolic regulation.

    CD BioSciences is dedicated to assisting researchers in academia and biopharma who are confronting an array of challenges. For customers interested in more information about these cell death solutions or any other signaling pathways, please visit CD BioSciences at

    About CD BioSciences
    CD BioSciences is a trusted research product supplier and CRO based in New York. With high-quality reagents and comprehensive services, CD BioSciences is a one-stop shop devoted to advancing signaling pathway studies for researchers. It is committed to fulfilling all your demands in the research of signaling pathways, and provides high-quality reagents and comprehensive solutions to support your innovative discoveries.

  • FB Icon Twitter Icon In-Icon
Contact Information